• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用集成机器学习方法预测前驱期阿尔茨海默病中的 tau 积累。

Prediction of tau accumulation in prodromal Alzheimer's disease using an ensemble machine learning approach.

机构信息

Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong-si, Gyeonggi-do, Republic of Korea.

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

出版信息

Sci Rep. 2021 Mar 11;11(1):5706. doi: 10.1038/s41598-021-85165-x.

DOI:10.1038/s41598-021-85165-x
PMID:33707488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7970986/
Abstract

We developed machine learning (ML) algorithms to predict abnormal tau accumulation among patients with prodromal AD. We recruited 64 patients with prodromal AD using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Supervised ML approaches based on the random forest (RF) and a gradient boosting machine (GBM) were used. The GBM resulted in an AUC of 0.61 (95% confidence interval [CI] 0.579-0.647) with clinical data (age, sex, years of education) and a higher AUC of 0.817 (95% CI 0.804-0.830) with clinical and neuropsychological data. The highest AUC was 0.86 (95% CI 0.839-0.885) achieved with additional information such as cortical thickness in clinical data and neuropsychological results. Through the analysis of the impact order of the variables in each ML classifier, cortical thickness of the parietal lobe and occipital lobe and neuropsychological tests of memory domain were found to be more important features for each classifier. Our ML algorithms predicting tau burden may provide important information for the recruitment of participants in potential clinical trials of tau targeting therapies.

摘要

我们开发了机器学习(ML)算法,以预测前驱期 AD 患者中异常 tau 积累。我们使用阿尔茨海默病神经影像学倡议(ADNI)数据集招募了 64 名前驱期 AD 患者。使用基于随机森林(RF)和梯度提升机(GBM)的监督 ML 方法。GBM 结合临床数据(年龄、性别、受教育年限)的 AUC 为 0.61(95%置信区间[CI] 0.579-0.647),结合临床和神经心理学数据的 AUC 更高为 0.817(95% CI 0.804-0.830)。在临床数据和神经心理学结果中增加皮质厚度等额外信息,AUC 最高可达 0.86(95% CI 0.839-0.885)。通过分析每个 ML 分类器中变量的影响顺序,发现顶叶和枕叶皮质厚度以及记忆域的神经心理学测试是每个分类器的更重要特征。我们预测 tau 负荷的 ML 算法可能为 tau 靶向治疗的潜在临床试验中的参与者招募提供重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/76a502cc0330/41598_2021_85165_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/0ef82b5bb3b6/41598_2021_85165_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/b7460b788afd/41598_2021_85165_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/76a502cc0330/41598_2021_85165_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/0ef82b5bb3b6/41598_2021_85165_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/b7460b788afd/41598_2021_85165_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e4/7970986/76a502cc0330/41598_2021_85165_Fig3_HTML.jpg

相似文献

1
Prediction of tau accumulation in prodromal Alzheimer's disease using an ensemble machine learning approach.使用集成机器学习方法预测前驱期阿尔茨海默病中的 tau 积累。
Sci Rep. 2021 Mar 11;11(1):5706. doi: 10.1038/s41598-021-85165-x.
2
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.
3
Comparing different algorithms for the course of Alzheimer's disease using machine learning.使用机器学习比较阿尔茨海默病病程的不同算法。
Ann Palliat Med. 2021 Sep;10(9):9715-9724. doi: 10.21037/apm-21-2013.
4
Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.机器学习算法有助于在普通人群中识别未被诊断的前驱期阿尔茨海默病患者。
J Prev Alzheimers Dis. 2019;6(3):185-191. doi: 10.14283/jpad.2019.10.
5
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.唐氏综合征成人阿尔茨海默病的血浆和脑脊液生物标志物:一项横断面研究。
Lancet Neurol. 2018 Oct;17(10):860-869. doi: 10.1016/S1474-4422(18)30285-0. Epub 2018 Aug 29.
6
Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.利用机器学习分析阿尔茨海默病神经影像学 (ADNI) 数据库,发现廉价、非侵入性的生物标志物可预测阿尔茨海默病的转化。
PLoS One. 2020 Jul 27;15(7):e0235663. doi: 10.1371/journal.pone.0235663. eCollection 2020.
7
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.阿尔茨海默病患者 Tau、Aβ 与皮质厚度和认知的相关性。
Neurology. 2019 Feb 5;92(6):e601-e612. doi: 10.1212/WNL.0000000000006875. Epub 2019 Jan 9.
8
Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.前驱期阿尔茨海默病的萎缩亚型与认知能力下降有关。
Brain. 2018 Dec 1;141(12):3443-3456. doi: 10.1093/brain/awy264.
9
MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.基于 MRI 的阿尔茨海默病样萎缩指数在临床前和前驱期阿尔茨海默病检测中的应用。
Aging (Albany NY). 2021 May 25;13(10):13496-13514. doi: 10.18632/aging.203082.
10
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.早发性和晚发性阿尔茨海默病中不同的 18F-AV-1451 tau PET 保留模式。
Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.

引用本文的文献

1
Mapping Alzheimer's disease pathology using free water through integrated analysis of plasma biomarkers, microstructural DTI metrics, and macrostructural MRI measures.通过对血浆生物标志物、微观结构扩散张量成像(DTI)指标和宏观结构磁共振成像(MRI)测量值进行综合分析,利用自由水绘制阿尔茨海默病病理图谱。
Sci Rep. 2025 Aug 21;15(1):30702. doi: 10.1038/s41598-025-14200-y.
2
Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach.用于预测轻度认知障碍老年人脑β淀粉样蛋白和tau蛋白状态的简单风险评分的开发:一种机器学习方法。
J Gerontol B Psychol Sci Soc Sci. 2025 Jun 10;80(7). doi: 10.1093/geronb/gbaf085.
3

本文引用的文献

1
The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.与阿尔茨海默病连续体中特定神经心理学缺陷相关的皮质神经解剖学
Dement Neurocogn Disord. 2019 Sep;18(3):77-95. doi: 10.12779/dnd.2019.18.3.77. Epub 2019 Oct 2.
2
Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers.利用多模态生物标志物预测淀粉样阳性轻度认知障碍患者的快速衰退。
Neuroimage Clin. 2019;24:101941. doi: 10.1016/j.nicl.2019.101941. Epub 2019 Jul 19.
3
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
Peripheral risk factors and their role in biomarker-based screening for dementia in the community.
外周风险因素及其在基于生物标志物的社区痴呆筛查中的作用。
Alzheimers Dement. 2024 Dec;20(12):8556-8565. doi: 10.1002/alz.14293.
4
Deep learning-based quantification of brain atrophy using 2D T1-weighted MRI for Alzheimer's disease classification.基于深度学习的脑萎缩量化分析:利用二维T1加权磁共振成像进行阿尔茨海默病分类
Front Aging Neurosci. 2024 Aug 14;16:1423515. doi: 10.3389/fnagi.2024.1423515. eCollection 2024.
5
Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure.利用机器学习推进阿尔茨海默病中Tau-PET定量分析:引入THETA,一种新型tau总结测量指标。
Res Sq. 2023 Oct 18:rs.3.rs-3290598. doi: 10.21203/rs.3.rs-3290598/v1.
6
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.阿尔茨海默病神经影像学倡议在阿尔茨海默病治疗时代:对 2021 年至 2022 年 ADNI 研究的回顾。
Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.
7
OViTAD: Optimized Vision Transformer to Predict Various Stages of Alzheimer's Disease Using Resting-State fMRI and Structural MRI Data.OViTAD:使用静息态功能磁共振成像和结构磁共振成像数据预测阿尔茨海默病各阶段的优化视觉Transformer
Brain Sci. 2023 Feb 3;13(2):260. doi: 10.3390/brainsci13020260.
8
Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer's Disease.人工智能在阿尔茨海默病临床试验中的潜在应用
Life (Basel). 2022 Feb 12;12(2):275. doi: 10.3390/life12020275.
阿尔茨海默病患者 Tau、Aβ 与皮质厚度和认知的相关性。
Neurology. 2019 Feb 5;92(6):e601-e612. doi: 10.1212/WNL.0000000000006875. Epub 2019 Jan 9.
4
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.[18F]flortaucipir 正电子发射断层扫描对阿尔茨海默病与其他神经退行性疾病的鉴别准确性。
JAMA. 2018 Sep 18;320(11):1151-1162. doi: 10.1001/jama.2018.12917.
5
The Neurotoxic Role of Extracellular Tau Protein.细胞外 Tau 蛋白的神经毒性作用。
Int J Mol Sci. 2018 Mar 27;19(4):998. doi: 10.3390/ijms19040998.
6
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
7
Cognitive Efficiency in Alzheimer's Disease is Associated with Increased Occipital Connectivity.阿尔茨海默病中的认知效率与枕叶连接性增加有关。
J Alzheimers Dis. 2017;57(2):541-556. doi: 10.3233/JAD-161164.
8
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Tau正电子发射断层扫描(PET)模式反映了阿尔茨海默病的临床和神经解剖学变异性。
Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.
9
PET Imaging of Tau Deposition in the Aging Human Brain.衰老人类大脑中tau蛋白沉积的正电子发射断层显像(PET)成像
Neuron. 2016 Mar 2;89(5):971-982. doi: 10.1016/j.neuron.2016.01.028.
10
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.阿尔茨海默病的多模态影像学:早期检测的有效性和实用性。
Lancet Neurol. 2015 Oct;14(10):1037-53. doi: 10.1016/S1474-4422(15)00093-9. Epub 2015 Aug 26.